Structure (Famotabsrx M Figure 01)
Famotidine
Product Images NDC 55648-937
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 55648-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Famotabsrx M Figure 02)
This is a medication label for Famotidine tablets. It indicates that each tablet contains 20 mg of Famotidine, USP. The medication must be stored in a well-closed, light-resistant container at a temperature between 20°-25°C (68°-77°F). The label also contains information about the manufacturers, which are Wockhardt Limited based in Mumbai, India, and Wockhardt USA LLC based in Parsippany, NJ, United States. The label does not contain information for indications, contraindications, side effects, or dosage.*
Label (Famotabsrx M Figure 03)
Each tablet of this product contains 40 mg of Famotidine, a medication used to reduce stomach acid production. It should be stored in a light-resistant container at a controlled room temperature of 20°-25°C (68°-77°F). This product is manufactured in Mumbai, India, and distributed by Wockhardt USA LLC in Parsippany, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
